Amneal Pharmaceuticals, Inc. (AMRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.46 |
| Open | 5.46 |
| Bid | 5.35 x 600 |
| Ask | 5.40 x 200 |
| Day's Range | 5.34 - 5.47 |
| 52 Week Range | 1.58 - 6.46 |
| Volume | |
| Avg. Volume | 1,496,343 |
| Market Cap | 1.654B |
| Beta (5Y Monthly) | 1.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.48 |
| Earnings Date | Feb 29, 2024 - Mar 04, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.25 |
Business WireAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
BRIDGEWATER, N.J., April 16, 2024--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Simply Wall St.Amneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past week
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
Business WireAmneal to Report First Quarter 2024 Results on May 3, 2024
BRIDGEWATER, N.J., April 10, 2024--Amneal to Report First Quarter 2024 Results on May 3, 2024
© 2024 Yahoo. All rights reserved.